Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) General and Admin. Expense: ₹5.2 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOFILCHEM Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
74 GF Score
Price ₹33.88
GF Value ₹41.64
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals General and Admin. Expense?

Biofil Chemicals & Pharmaceuticals NSE:BIOFILCHEM +1.80% 74 General and Admin. Expense is ₹5.2 Mil as of Mar. 2026. GuruFocus rates NSE:BIOFILCHEM with a GF Score™ of 74/100 and a GF Value™ of ₹41.64 (Modestly Undervalued). The stock has 7 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Biofil Chemicals & Pharmaceuticals's General and Admin. Expense for the three months ended in Mar. 2026 was ₹2.5 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.2 Mil.

Biofil Chemicals & Pharmaceuticals General and Admin. Expense Related Terms

Biofil Chemicals & Pharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Biofil Chemicals & Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals General and Admin. Expense Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 1.36 1.40 4.16 6.09

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 0.59 0.60 1.42 2.55
NSE:BIOFILCHEM
74GF Score
Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofil Chemicals & Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ₹5.2 Mil mean?
Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) has a General and Admin. Expense of ₹5.2 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Biofil Chemicals & Pharmaceuticals and its competitors.
Is Biofil Chemicals & Pharmaceuticals' General and Admin. Expense too high?
Biofil Chemicals & Pharmaceuticals' current General and Admin. Expense is ₹5.2 Mil. Overall, Biofil Chemicals & Pharmaceuticals has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biofil Chemicals & Pharmaceuticals' General and Admin. Expense compare to ZTS and UTHR?
Biofil Chemicals & Pharmaceuticals' General and Admin. Expense of ₹5.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Biofil Chemicals & Pharmaceuticals and its competitors. Biofil Chemicals & Pharmaceuticals's current General and Admin. Expense is ₹5.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofil Chemicals & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹41.64, compared to a current price of ₹33.88 — trading 18.6% below its estimated fair value. The current General and Admin. Expense is ₹5.2 Mil. Biofil Chemicals & Pharmaceuticals' overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM), the current General and Admin. Expense is ₹5.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹33.88 is trading 18.6% below its estimated GF Value™ of ₹41.64. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:BIOFILCHEM:

  • General and Admin. Expense: ₹5.2 Mil
  • GF Value™: ₹41.64 vs. price of ₹33.88 (18.6% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the NSE:BIOFILCHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges 524396:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
74GF Score

Get the complete analysis for NSE:BIOFILCHEM

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.88
Price
₹41.64
GF Value